The global Discovery & Targeted Proteomics Service market size is predicted to grow from US$ 2441 million in 2024 to US$ 4832 million in 2030; it is expected to grow at a CAGR of 12.1% from 2024 to 2030.

Discovery proteomics involves unbiased, large-scale analysis of proteins in complex biological samples, while targeted proteomics focuses on known proteins or specific pathways. The two complement each other. Non-targeted proteomics provides extensive protein information and the discovery of potential biomarkers, laying the foundation for subsequent in-depth research in targeted proteomics, while targeted proteomics can verify and functionally evaluate key proteins identified in non-targeted analysis, thereby achieving a more detailed understanding of biology.

United States market for Discovery & Targeted Proteomics Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Discovery & Targeted Proteomics Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Discovery & Targeted Proteomics Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Discovery & Targeted Proteomics Service players cover RayBiotech, Inc., Inotiv, Sapient Bioanalytics, LLC, Biogenity, Proteome Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

LPI (LP Information) newest research report, the Discovery & Targeted Proteomics Service Industry Forecast looks at past sales and reviews total world Discovery & Targeted Proteomics Service sales in 2023, providing a comprehensive analysis by region and market sector of projected Discovery & Targeted Proteomics Service sales for 2024 through 2030. With Discovery & Targeted Proteomics Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Discovery & Targeted Proteomics Service industry.

This Insight Report provides a comprehensive analysis of the global Discovery & Targeted Proteomics Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Discovery & Targeted Proteomics Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Discovery & Targeted Proteomics Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Discovery & Targeted Proteomics Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Discovery & Targeted Proteomics Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Discovery & Targeted Proteomics Service market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Discovery Proteomics
    Targeted Poteomics

Segmentation by Application:

    Screening and Validation of Disease Biomarkers
    Drug Development and Precision Medicine
    Protein Function and Interaction Studies
    Other

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    RayBiotech, Inc.
    Inotiv
    Sapient Bioanalytics, LLC
    Biogenity
    Proteome Sciences
    VProteomics
    Creative Proteomics
    Charles River Laboratories
    MtoZ Biolabs
    Panome Bio
    PolyQuant GmbH
    MS Bioworks
    LABTOO
    BGI Genomics
    Biotech Pack
    APPLIED PROTEIN TECHNOLOGY
    OBiO Technology ( Shanghai ) Corp.,Ltd.
    Suzhou PANOMIX Biomedical Tech Co.,Ltd
    Novogene
    OeBiotech
    ChomiX Biotech Co., Ltd